Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. - Wikidata - wikimedia - TriplyDB

Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use.

Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use.

http://www.wikidata.org/entity/Q44352147

about

The fitness costs of antibiotic resistance mutations Costs of antibiotic resistance - separating trait effects and selective effects Antibiotic resistance patterns of Escherichia coli urinary isolates and comparison with antibiotic consumption data over 10 years, 2005-2014.Molecular characterisation of trimethoprim resistance in Escherichia coli and Klebsiella pneumoniae during a two year intervention on trimethoprim use Reversibility of antibiotic resistance Antimicrobial management and appropriateness of treatment of urinary tract infection in general practice in Ireland Plasmid-encoded tetracycline efflux pump protein alters bacterial stress responses and ecological fitness of Acinetobacter oleivorans.Fitness of Escherichia coli strains carrying expressed and partially silent IncN and IncP1 plasmids.Varying high levels of faecal carriage of extended-spectrum beta-lactamase producing Enterobacteriaceae in rural villages in Shandong, China: implications for global health.Within-population distribution of trimethoprim resistance in Escherichia coli before and after a community-wide intervention on trimethoprim use Impact of outpatient antibiotic use on carriage of ampicillin-resistant Escherichia coli.Association of composite IS26-sul3 elements with highly transmissible IncI1 plasmids in extended-spectrum-beta-lactamase-producing Escherichia coli clones from humans Limits to compensatory adaptation and the persistence of antibiotic resistance in pathogenic bacteria.Low fitness cost of the multidrug resistance gene cfr.An Audit-Based, Infectious Disease Specialist-Guided Antimicrobial Stewardship Program Profoundly Reduced Antibiotic Use Without Negatively Affecting Patient Outcomes.A pivot mutation impedes reverse evolution across an adaptive landscape for drug resistance in Plasmodium vivax Non-prescription antimicrobial use worldwide: a systematic review Awareness of antibiotic resistance and antibiotic prescribing in UTI treatment: a qualitative study among primary care physicians in Sweden Foodborne urinary tract infections: a new paradigm for antimicrobial-resistant foodborne illness A modeling framework for the evolution and spread of antibiotic resistance: literature review and model categorization.Clusters of Antibiotic Resistance Genes Enriched Together Stay Together in Swine Agriculture Antimicrobial susceptibility pattern and epidemiology of female urinary tract infections in South Korea, 2010-2011.Approach to a positive urine culture in a patient without urinary symptoms.Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance.Identification of bacterial plasmids based on mobility and plasmid population biology.Emergence and spread of antibiotic resistance following exposure to antibiotics.Antimicrobial agent exposure and the emergence and spread of resistant microorganisms: issues associated with study design.Methenamine: a forgotten drug for preventing recurrent urinary tract infection in a multidrug resistance era.Selection and evolution of resistance to antimicrobial drugs.Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria.Prediction of antibiotic resistance: time for a new preclinical paradigm?Normalized resistance interpretation, the NRI method: Review of NRI disc test applications and guide to calculations.Epistasis and the Evolution of Antimicrobial Resistance.Host population structure impedes reversion to drug sensitivity after discontinuation of treatment.Studying the effect of administration route and treatment dose on the selection of enrofloxacin resistance in commensal Escherichia coli in broilers.Integron-Associated DfrB4, a Previously Uncharacterized Member of the Trimethoprim-Resistant Dihydrofolate Reductase B Family, Is a Clinically Identified Emergent Source of Antibiotic Resistance.Antimicrobial resistance in equine faecal Escherichia coli isolates from North West England.Evolution of Cost-Free Resistance under Fluctuating Drug Selection in Pseudomonas aeruginosa.Metabolic Compensation of Fitness Costs Is a General Outcome for Antibiotic-Resistant Pseudomonas aeruginosa Mutants Overexpressing Efflux Pumps.Normalized resistance interpretation as a tool for establishing epidemiological MIC susceptibility breakpoints.

P2860

Q26825334-728956B3-C982-485C-9791-C91033B7EE7C Q28082095-62E636BD-DCDD-414C-B4A8-D940E900D518 Q31152845-0DFF461D-4F8C-4F54-B3E0-FAE7389BB503 Q33532609-48EDF60D-8DA3-4C4E-9FB3-C0AE7847889B Q33667524-3DCDBBB8-0E71-4357-ADC3-28E30810B204 Q34038633-434257A0-ADE0-4DC0-BAFF-CA04CD790A80 Q34207402-F51C01AC-2131-4212-91E8-A86F15B68FAB Q34219902-82993F7F-893F-44A5-A18B-8C51A0172C78 Q34535865-EB4A3F1A-AB11-43A8-8A9F-1C6D1265446F Q34597729-8EBC4925-4341-4D33-B023-5A788A15A544 Q34737220-9D824222-CFF3-4C89-B3E0-7D7F4F1E990D Q34932884-63BD6CBF-C1E5-4999-9892-00E5A2640AF4 Q35069590-5F1E2BCD-9351-4A77-B8FA-ACF56454B551 Q35139469-2C3C183F-66B8-4E24-B8AF-BE58FCD0E546 Q36051958-0C139F0F-3850-4923-A582-0FCB9DF2D6DC Q36503457-95E9DCCC-DD6A-4892-BBAA-85A6B3452AF0 Q36529047-11271DE3-D308-4C79-9D1A-08E795E0105A Q36654018-360154F6-2D22-4409-8732-6E8BB72C14B9 Q36660768-45FB974C-657C-467B-8ABC-4E82AC5FF930 Q37078552-F9238376-557F-4DE0-89A1-0361126C82A3 Q37123068-C665F23E-2C42-4D60-9C7E-FC77C13DA86C Q37263346-0A0F58FB-9B79-4433-A81A-FC6BE2AE0171 Q37550409-1EC7C7FA-03EE-4963-B922-90D91DC4BBB7 Q37876027-31CADD7C-F728-41BE-A910-0780F081F4B5 Q37895333-8F60C9B2-D176-4854-BEDD-BFE0493B8C14 Q37896674-F5A73F02-E4D3-4FD3-9C73-F20A3D737172 Q38069872-1AF33D56-BC46-4B4D-B2E3-391EEE17DA86 Q38201118-9B2E32B2-E0C8-45D5-B9FC-11D2D7B0295A Q38220609-346DF11D-5A50-496C-926A-36026949E2BD Q38384662-483892C3-1D31-40B5-AA3A-2709153CD35E Q38649580-A0F934DC-9F63-4B6B-99AB-F78F56168FF0 Q39012323-8FE671F5-7DEA-4538-8F93-4895A291FF88 Q39162611-27F2B879-F9E5-4059-AC3F-468BD6334E38 Q40084961-B5B3C1CF-2971-479A-932E-F1CAAF8154FF Q40238353-00B17942-4992-4969-8C0A-71D36DD62939 Q40315357-29E8EA2C-9E45-4036-B6FD-B0D65CBF0E07 Q40487104-A7826D04-E1F9-4F01-AD5D-1F0250C2DA9B Q41066625-D8E2A6E7-410E-4CE8-9A83-63FCCCB79A88 Q41126931-7184D413-6D3D-4E42-9856-6B80830371F4 Q41428630-88934E4A-782A-4339-8513-D7DE975D541C

P2860

Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use.

http://www.wikidata.org/entity/Q44352147

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Little evidence for reversibil ...... reduction in trimethoprim use.

@en

Little evidence for reversibil ...... reduction in trimethoprim use.

@nl

type

label

Little evidence for reversibil ...... reduction in trimethoprim use.

@en

Little evidence for reversibil ...... reduction in trimethoprim use.

@nl

prefLabel

Little evidence for reversibil ...... reduction in trimethoprim use.

@en

Little evidence for reversibil ...... reduction in trimethoprim use.

@nl

P1433

Q44352147-1E7C7619-6080-41F3-9B59-39D672FFFC49

P1476

Q44352147-AE7A010C-742B-4159-8F2B-2E46A26BAF48

P2093

Q44352147-0A540562-3B2A-4389-AC74-E4ABE6653F57

Q44352147-0F20B19A-DE98-41FC-B432-DDBFC90C92D7

Q44352147-38FC0959-AD83-4044-9857-6400F37BD887

Q44352147-3BCC0001-169D-4ED7-9265-9E228E62173C

Q44352147-5F117730-822B-41F1-A44D-891A69A57251

Q44352147-8569A700-0A5B-4023-989F-5232382EBB17

Q44352147-8F878403-6237-4872-B3BA-622E752B72D8

Q44352147-915BDBF4-337B-4070-AE4D-8BF7B1B9A071

Q44352147-ED30D664-6838-47DB-8675-3E7B49FD88B7

P2860

Q44352147-04CC5E4E-9FA2-446B-BF63-D0402F0A0766

Q44352147-071871E3-7F57-4E05-A7EE-AA8B0CE2EDBD

Q44352147-0790716B-F625-4E88-90BE-CC47E020FE64

Q44352147-08F2C9B3-2FB0-43DD-95B2-7590CD64AA9C

Q44352147-0E651173-8E79-4CE4-90C4-F2B49CDA241B

Q44352147-10C7F264-3A7C-4359-ADD8-986CC4D4142B

Q44352147-2B42A29B-9414-4AF9-9E8B-39234AA5FFCC

Q44352147-307D4449-6799-416C-B827-B7FAB78FE9EC

Q44352147-348AB6C9-F6B0-4F75-88C4-42ACBCA62165

Q44352147-4249DCEB-EFE2-43C3-9CD6-8AB0B00E0EA8

P304

Q44352147-2AB0503D-15E5-4200-92BA-82F3D69C1E3E

P31

Q44352147-9D628FE9-9A44-46C4-87C2-215A908D9626

P356

Q44352147-EC22D2B2-8807-48C5-8D12-9F18D842A11F

P407

Q44352147-D62A0FF6-1288-469D-93F2-5FAC184F9DC8

P433

Q44352147-EFFC782A-F5BE-4DE9-89F8-FFB3A3BDDF09

P478

Q44352147-1A303EA1-555E-4809-B5E3-A7D0388F78F3

P577

Q44352147-16D8765B-F5E4-49D7-B44A-5496C840C420

P5875

Q44352147-E58A135E-0ABA-428E-988D-4D2546550915

P698

Q44352147-5A7AC2D1-45E9-49D0-AEFE-ACC4262A8C86

P356

P1433

Journal of Antimicrobial Chemotherapy

P1476

Little evidence for reversibil ...... reduction in trimethoprim use.

@en

P2093

A Runehagen

http://www.w3.org/2001/XMLSchema#string

D I Andersson

http://www.w3.org/2001/XMLSchema#string

G Kahlmeter

http://www.w3.org/2001/XMLSchema#string

H Cars

http://www.w3.org/2001/XMLSchema#string

K Abelson-Storby

http://www.w3.org/2001/XMLSchema#string

M Sjölund-Karlsson

http://www.w3.org/2001/XMLSchema#string

M Sundqvist

http://www.w3.org/2001/XMLSchema#string

O Cars

http://www.w3.org/2001/XMLSchema#string

P Geli

http://www.w3.org/2001/XMLSchema#string

P2860

Pathogenesis of group A streptococcal infections

Clonal spread of resistant pneumococci despite diminished antimicrobial use.

Reduction in outpatient antibiotic sales for pre-school children: interrupted time series analysis of weekly antibiotic sales data in Sweden 1992-2002.

The biological cost of antibiotic resistance.

Fitness cost of chromosomal drug resistance-conferring mutations

Antibiotic resistance in the absence of selective pressure.

Resistance to trimethoprim and sulfonamides.

The rise and fall of antimicrobial resistance.

Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

The biological cost of mutational antibiotic resistance: any practical conclusions?

P304

350-360

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKP387

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38077795

http://www.w3.org/2001/XMLSchema#string

P698

19900952

http://www.w3.org/2001/XMLSchema#string